10x Genomics, Inc.
A life-sciences technology company that makes instruments, consumables, and software for studying biology at the level of individual cells and their spatial context, using its Chromium and Visium platforms. Founded in 2012 in Pleasanton, California, by Serge Saxonov, Ben Hindson, and Kevin Ness, the company's name reflects their goal of a ten-fold, or "10x," improvement in biological resolution rather than incremental progress.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| ARK Investment Management LLC | 13G/APassive | 8.56% | 10.00M | Aug 14, 2026 |
| Catherine D. Wood | 13G/APassive | 8.56% | 10.00M | Aug 14, 2026 |
| Vanguard Capital Management | 13GPassive | 5.24% | 6.17M | Apr 29, 2026 |
| Vanguard Portfolio Management | 13GPassive | 5.93% | 6.98M | Apr 28, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 25, 2026 |
| FMR LLC | 13G/APassive | 15.6% | 18.54M | Mar 6, 2026 |
| Abigail P. Johnson | 13G/APassive | 15.6% | 18.54M | Mar 6, 2026 |
| Amova Asset Management Americas, Inc. | 13G/APassive | 4.7% | 5.38M | Nov 13, 2025 |
| Sumitomo Mitsui Trust Group, Inc. | 13G/APassive | 4.7% | 5.38M | Oct 27, 2025 |
| Amova Asset Management Co., Ltd. | 13G/APassive | 4.7% | 5.38M | Oct 27, 2025 |